• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Evonetix

Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices

September 9, 2020
Lyell Immunopharma

Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors

September 2, 2020
Cerevance

Biotech Startup Cerevance Extends Series B to $65 Million

July 21, 2020
Kinnate Biopharma

Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer

July 8, 2020
Inscripta

Writing in the Language of DNA: Kevin Ness on The Long Run

July 6, 2020
Relay Therapeutics

Relay Therapeutics tees up $200M IPO to push a trio of oncology meds

June 24, 2020
Bit Bio Limited

Sure, Bit Bio got some significant cash for its cell coding work. But it’s the insiders who are backing them that will garner the attention

June 13, 2020
DNAnexus, Inc.

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data

June 9, 2020
insitro

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

May 26, 2020
Mindstrong, Inc.

With an ex-Uber exec as its new CEO, digital mental health service Mindstrong raises $100 million

May 21, 2020
Page 9 of 26« First«...7891011...20...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close